Crohn's Disease and Colitis Trial, Recruiting (NCT06690632)

Crohn's Disease and Colitis Trial, Recruiting NCT06690632 Sponsor: University Hospital, Toulouse Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06690632 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Crohn's Disease.
Your gastroenterologist (gut specialist) has decided you need a type of MRI scan of the intestines called an MRE (MR Enterography).

Who may not be able to join:

You are under 18 years old.
You are not able to give your own informed consent to take part in the study.
You are under legal guardianship or a similar form of supervised legal protection.
You have an allergy to PEG (polyethylene glycol), a substance sometimes used as a laxative or bowel preparation (confirm with trial site).
You have a reason why you cannot have an MRI scan, such as being pregnant, having a pacemaker, or having severe claustrophobia (fear of enclosed spaces).
You have a condition called phenylketonuria (PKU), which means you cannot receive a medication called phloroglucinol used in the study (confirm with trial site).
You have a reason why you cannot receive gadolinium, which is a contrast dye used during MRI scans — this includes having significant kidney problems (with a filtration rate below 30 mL/1.73m²), being pregnant, or having an allergy to gadolinium.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06690632

Sponsor: University Hospital, Toulouse

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

More information: https://clinicaltrials.gov/study/NCT06690632

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Crohn's Disease.
Your gastroenterologist (gut specialist) has decided you need a type of MRI scan of the intestines called an MRE (MR Enterography).

Who may not be able to join:

You are under 18 years old.
You are not able to give your own informed consent to take part in the study.
You are under legal guardianship or a similar form of supervised legal protection.
You have an allergy to PEG (polyethylene glycol), a substance sometimes used as a laxative or bowel preparation (confirm with trial site).
You have a reason why you cannot have an MRI scan, such as being pregnant, having a pacemaker, or having severe claustrophobia (fear of enclosed spaces).
You have a condition called phenylketonuria (PKU), which means you cannot receive a medication called phloroglucinol used in the study (confirm with trial site).
You have a reason why you cannot receive gadolinium, which is a contrast dye used during MRI scans — this includes having significant kidney problems (with a filtration rate below 30 mL/1.73m²), being pregnant, or having an allergy to gadolinium.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Toulouse

Registry

ClinicalTrials.gov

Start date

29 January 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Bowel distension

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov